Oncology
Biocare MedicalBioImageneBio-Rad Laboratories IncbioTheranosticsHemosureQIAGENQuidel CorpTherakos IncThermo Fisher Scientific
Read More
Search Results for: lung cancer
Abbott, GlaxoSmithKline Test to Help Select Candidate Patients for Cancer Immunotherapy
Abbott announced that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.
Read MorePredicting Prognosis and Treatment Response in Subset of Pancreatic Cancer Patients
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read MoreClarient Launches New Lung Cancer Test
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, has announced the commercial launch of a new lung cancer test, Clarient Insight Dx Pulmotype.
Read MoreQIAGEN Acquires Exclusive Licence for Key PI3K gene
QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
Read More